Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Was J.P. Morgan a drag? Is it time to give up on Aduhelm? And how many guitars is too many? All that and more...

  • Was J.P. Morgan a drag? Is it time to give up on Aduhelm? And how many guitars is too many? — All this and much more on the latest episode of "The Readout LOUD" #podcast. Listen here: https://t.co/6AQYjvIWlY - view on twitter

Teladoc CEO Jason Gorevic says the company plans to gradually embrace more risk-sharing when it comes to the cost of caring for its...

“Pharma bro” Martin Shkreli was ordered to pay $64 million in profits and was banned for life from the pharmaceutical industry for an infamous...

Volunteers like me let Moderna test its experimental vaccine and booster on us in order to help end this pandemic, not to make more...

  • Opinion: In July 2020, I volunteered to be in Moderna’s Covid-19 vaccine trial. If I knew then what I know now about the company’s quest for profits, I wouldn’t have done that. https://t.co/cfxyDzweWN - view on twitter

A devastating diagnosis. A fight against time. And an “epic” journey that galvanized a new movement for ALS...

Welcome to STAT Madness — a contest to find the best innovations from the top research institutions in the United States. Think your school...

Medicare may have released a plan to restrict access to Biogen’s controversial Alzheimer’s drug, but the biggest losers may actually be other drug makers...

Medicare’s proposal that it will cover Alzheimer’s drugs such as Biogen’s embattled Aduhelm only in clinical trials could have a simple but difficult result...

CAR-T cell therapy has been a boon for treating blood cancers. Now, scientists are working on next-generation approaches to treat more types of...